Evidence map›Paper›PMID 34882740›Full record

ArticlePloS one2021

Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes.

Diego Casas-Deza, Vanesa Bernal-Monterde, Angel Nicolás Aranda-Alonso, Enrique Montil-Miguel, Ana Belen Julián-Gomara, Laura Letona-Giménez, Jose M Arbones-Mainar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. [Recommendations on prevention and treatment of respiratory infections in institutionalised older people].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Gut bacteria: an etiological agent in human pathological conditions.Frontiers in cellular and infection microbiology · 2024
    Review
  7. Article
  8. Observational
  9. Observational
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Diego Casas-DezaGastroenterology Department, Miguel Servet University Hospital, Zaragoza, Spain.ORCID 0000-0001-6883-8940
Vanesa Bernal-MonterdeGastroenterology Department, Miguel Servet University Hospital, Zaragoza, Spain.
Angel Nicolás Aranda-AlonsoInternal Medicine Department, Miguel Servet University Hospital, Zaragoza, Spain.
Enrique Montil-MiguelGastroenterology Department, Miguel Servet University Hospital, Zaragoza, Spain.
Ana Belen Julián-GomaraGastroenterology Department, Miguel Servet University Hospital, Zaragoza, Spain.
Laura Letona-GiménezInternal Medicine Department, Miguel Servet University Hospital, Zaragoza, Spain.
Jose M Arbones-MainarInstituto de Investigación Sanitaria (IIS) Aragon, Zaragoza, Spain.ORCID 0000-0002-8982-3737
Hospital Universitario Miguel Servet · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk for severe COVID-19 increases with age. Different vaccination strategies are currently being considered, including those aimed at slowing down transmission and those aimed at providing direct protection to those most at risk.

methodsThe objectives of the current study were i) to assess age-related incidence and survival between PCR-diagnosed COVID-19 cases (n = 61,993) in the Autonomous Community of Aragon from March to November 2020, and ii) to characterize age differences regarding the course of the disease in hospitalized patients in a tertiary university hospital.

resultsWe found a similar incidence of COVID-19 in individuals between 10 and 79 years. Incidence increased in those over 80 years possibly because of the elevated transmission within the nursing homes. We observed a profound disparity among age groups; case fatality rates (CFRs) were near 0 in cases younger than 39 years throughout different waves. In contrast, there was an age-dependent and progressive increase in the CFRs, especially during the first pandemic wave. SARS-CoV-2 infection caused a more severe and rapid progression in older patients. The elderly required faster hospitalization, presented more serious symptoms on admission, and had a worse clinical course. Hospitalized older individuals, even without comorbidities, had an increased mortality risk directly associated with their age. Lastly, the existence of comorbidities dramatically increased the CFRs in the elderly, especially in males.

conclusionThe elevated incidence of COVID-19 and the vulnerability of the elderly call for their prioritization in vaccination and targeted prevention measures specifically focused on this aged population.

Indexed as

Immunization ProgramsAdolescentAdultAgedAged, 80 and overAge FactorsChildComorbidityCOVID-19FemaleHumansIncidenceMaleMiddle AgedSARS-CoV-2Spain

Identifiers

PMID34882740
PMCPMC8659616
OpenAlexW4200451787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.